Recent News at AdventHealthMD
-
Science and InnovationAdventHealth Involved in Research to Evaluate First Potential Disease-Modifying Treatment for Epileptic Patients with Dravet Syndrome
Estimated read time: 4 minutesUnder the leadership of principal investigator Ki Hyeong Lee, MD, MS, medical director of AdventHealth for Children’s pediatric epilepsy center in Orlando, AdventHealth Orlando has been one of two...
-
Science and InnovationAdventHealth Neuroscience Institute Secures New Gamma Knife Radiosurgery Platform to Advance Patient Care
Estimated read time: 2 minutesIn April 2024, the AdventHealth Neuroscience Institute became the first in Central Florida to treat brain patients with the Elekta Esprit Gamma Knife. This advanced stereotactic radiosurgery (SRS)...
-
Science and InnovationAdventHealth for Children Collaborating with n-Lorem Foundation to Provide Personalized Treatments to Patients with Nano-rare Genetic Diseases
Estimated read time: 4 minutesThe n-Lorem Foundation recently selected AdventHealth for Children in Orlando as one of the first institutions in Florida to collaborate with providing personalized antisense oligonucleotide (ASO)...
-
Science and InnovationInnovative Spring Sees Three Groundbreaking Cardiovascular Procedures Performed by AdventHealth Physicians
Estimated read time: 2 minutesThis spring, AdventHealth marked significant advancements in patient care with three “firsts” representing a leap forward in treatment of cardiovascular conditions.
-
Science and InnovationGroundbreaking Ozempic study – Conducted in Part at AdventHealth – Could Increase Access for People with Chronic Kidney Disease
Estimated read time: 3 minutesA recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.